Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database.
Charan J, Dutta S, Kaur R, Bhardwaj P, Sharma P, Ambwani S, Jahan I, Abubakar AR, Islam S, Hardcastle TC, Rahman NAA, Lugova H, Haque M.
Charan J, et al. Among authors: dutta s.
Expert Opin Drug Saf. 2021 Sep;20(9):1125-1136. doi: 10.1080/14740338.2021.1946513. Epub 2021 Jun 28.
Expert Opin Drug Saf. 2021.
PMID: 34162299
Free PMC article.